Prismack Biotechnics Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 10-12-2024
- Paid Up Capital ₹ 5.67 Cr
as on 10-12-2024
- Company Age 30 Year, 4 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 24.78 Cr
as on 10-12-2024
- Satisfied Charges ₹ 7.64 Cr
as on 10-12-2024
- Revenue %
(FY 2021)
- Profit 0.54%
(FY 2021)
- Ebitda 6.55%
(FY 2021)
- Net Worth -11.70%
(FY 2021)
- Total Assets -6.52%
(FY 2021)
About Prismack Biotechnics
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.67 Cr.
The company currently has active open charges totaling ₹24.78 Cr. The company has closed loans amounting to ₹7.64 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nannapaneni Choudary, Venkata Parvathaneni, and Ammemma Yelavarti serve as directors at the Company.
- CIN/LLPIN
U99999TG1994PLC018265
- Company No.
018265
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
07 Sep 1994
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Prismack Biotechnics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nannapaneni Choudary  | Director | 20-May-2024 | Current |
| Venkata Parvathaneni | Director | 20-May-2024 | Current |
| Ammemma Yelavarti | Director | 05-Nov-2024 | Current |
Financial Performance of Prismack Biotechnics.
Prismack Biotechnics Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 0.54% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prismack Biotechnics?
In 2021, Prismack Biotechnics had a promoter holding of 85.76% and a public holding of 14.24%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 18 Nov 2009 | ₹24.78 Cr | Open |
Idbi Bankltd. Creation Date: 13 Sep 1995 | ₹6.36 Cr | Satisfied |
Idbi Bankltd. Creation Date: 08 Sep 1995 | ₹1.28 Cr | Satisfied |
How Many Employees Work at Prismack Biotechnics?
Unlock and access historical data on people associated with Prismack Biotechnics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prismack Biotechnics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prismack Biotechnics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
